You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0165 Effectiveness and Safety of Biosimilar Infliximab (CT-P13) in A Real-Life Setting in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
FRI0165 Effectiveness and Safety of Biosimilar Infliximab (CT-P13) in A Real-Life Setting in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 20161201
Aug 2016803
Sep 2016902
Oct 20161901
Nov 20164604
Dec 2016700
Jan 20171900
Feb 20172501
Mar 20172400
Apr 20171400
May 20172302
Jun 2017800
Jul 20171000
Aug 20171400
Sep 20171600
Oct 20171401
Nov 20171400
Dec 20172200
Jan 2018600
Feb 20181600
Mar 20181000
Apr 20182600
May 20185204
Jun 20181200
Jul 20181600
Aug 20181001
Sep 2018801
Oct 2018801
Nov 20182000
Dec 2018400
Jan 2019600
Feb 2019400
Mar 2019100
Apr 20191400
May 2019400
Jun 2019200
Jul 20191502
Aug 2019200
Sep 2019200
Oct 2019400
Nov 20191601
Dec 20191200
Jan 2020401
Feb 2020200
Mar 2020300
Apr 2020400
Jun 2020400
Jul 2020600
Aug 2020200
Sep 20201800
Nov 2020400
Dec 2020200
Jan 2021200
Sep 2021100
Oct 2021600
Nov 2021800
Dec 20211600
Jan 2022600
Feb 2022400
Mar 2022600
Apr 2022900
May 2022800
Jun 20221800
Jul 2022801
Aug 20221300
Sep 20221200
Oct 2022800
Nov 20221500
Dec 2022800
Jan 2023900
Feb 2023800
Mar 2023600
May 2023400
Jun 2023200
Jul 2023500
Aug 2023100
Sep 2023600
Nov 2023300
Dec 20231400
Jan 2024400
Feb 2024300
Mar 20243700
Total873027